Support PenkeCI Global Balanced Corporate F
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRFS.NASDAQ | Grifols SA ADR | USA | Healthcare | Drug Manufacturers - General | 2024-09-30 | 0.087 | 2.59 | 593.8k | $7.3m | $4.3m |
| |||||||||||||
| INOV.NASDAQ | INOV.NASDAQ | - | - | - | - | 0.084 | 1.229 | 130k | - | - | ||||||||||||||
| INOV.NYSE ARC | INOV.NYSE ARC | - | - | - | - | 0.084 | 1.229 | 130k | - | - |
Comments
How you think about this?